Viewing Study NCT02983604

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:21 PM
Ignite Modification Date: 2026-03-15 @ 4:17 AM
Study NCT ID: NCT02983604
Status: TERMINATED
Last Update Posted: 2019-08-07
First Post: 2016-12-02
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: GS-5829 in Combination With Fulvestrant or Exemestane in Women With Advanced Estrogen Receptor Positive, HER2 Negative-Breast Cancer
Sponsor: Gilead Sciences
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Estrogen Receptor Positive HER2- Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Exemestane View
None Aromasin View
None Fulvestrant View
None Faslodex View
None Breast Cancer View
None HER 2- View
None Estrogen receptor positive View